Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 4
1979 1
1980 1
1981 1
1982 5
1983 5
1984 7
1985 6
1986 4
1987 5
1988 7
1989 8
1990 5
1991 9
1992 12
1993 5
1994 6
1995 4
1996 3
1997 1
1998 4
1999 3
2000 10
2001 6
2002 4
2003 4
2004 5
2005 6
2006 4
2007 5
2008 8
2009 7
2010 5
2011 3
2012 5
2013 4
2014 6
2015 4
2016 7
2017 8
2018 3
2019 3
2020 3
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. Among authors: higashihara e. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
[Urolithiasis in hemodialysis patients].
Nutahara K, Higashihara E. Nutahara K, et al. Among authors: higashihara e. Nihon Rinsho. 2004 Jun;62 Suppl 6:370-3. Nihon Rinsho. 2004. PMID: 15250327 Review. Japanese. No abstract available.
[Urological cancer].
Kato M, Higashihara E. Kato M, et al. Among authors: higashihara e. Gan To Kagaku Ryoho. 2005 Sep;32(9):1255-9. Gan To Kagaku Ryoho. 2005. PMID: 16184920 Japanese.
Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD.
Higashihara E, Nutahara K, Itoh M, Okegawa T, Tambo M, Yamaguchi T, Nakamura Y, Taguchi S, Kaname S, Yokoyama K, Yoshioka T, Fukuhara H. Higashihara E, et al. Kidney Int Rep. 2021 Dec 8;7(2):270-281. doi: 10.1016/j.ekir.2021.11.034. eCollection 2022 Feb. Kidney Int Rep. 2021. PMID: 35155866 Free PMC article.
PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney Disease.
Shigemori K, Higashihara E, Itoh M, Yoshida H, Yamamoto K, Nutahara K, Shiokawa Y, Kaname S, Tambo M, Yamaguchi T, Taguchi S, Yoshioka T, Yokoyama K, Fukuhara H. Shigemori K, et al. Among authors: higashihara e. J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105943. doi: 10.1016/j.jstrokecerebrovasdis.2021.105943. Epub 2021 Jun 25. J Stroke Cerebrovasc Dis. 2021. PMID: 34175641 Free article.
Estimation of Changes in Kidney Volume Growth Rate in ADPKD.
Higashihara E, Fukuhara H, Ouyang J, Lee J, Nutahara K, Tanbo M, Yamaguchi T, Taguchi S, Muto S, Kaname S, Miyazaki I, Horie S. Higashihara E, et al. Kidney Int Rep. 2020 Jun 20;5(9):1459-1471. doi: 10.1016/j.ekir.2020.06.011. eCollection 2020 Sep. Kidney Int Rep. 2020. PMID: 32954070 Free PMC article.
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.
Gansevoort RT, van Gastel MDA, Chapman AB, Blais JD, Czerwiec FS, Higashihara E, Lee J, Ouyang J, Perrone RD, Stade K, Torres VE, Devuyst O; TEMPO 3:4 Investigators. Gansevoort RT, et al. Among authors: higashihara e. Kidney Int. 2019 Jul;96(1):159-169. doi: 10.1016/j.kint.2018.11.044. Epub 2019 Mar 9. Kidney Int. 2019. PMID: 30898339 Free PMC article. Clinical Trial.
209 results